▶ 調査レポート

ベータニコチンアミドモノヌクレオチド (NMN)の世界市場2023年:含有率98%以上、含有率98%以下

• 英文タイトル:Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2023

QYResearchが調査・発行した産業分析レポートです。ベータニコチンアミドモノヌクレオチド (NMN)の世界市場2023年:含有率98%以上、含有率98%以下 / Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2023 / MRC23Q30789資料のイメージです。• レポートコード:MRC23Q30789
• 出版社/出版日:QYResearch / 2023年3月
• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(2-3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥435,000 (USD2,900)▷ お問い合わせ
  Enterprise License¥870,000 (USD5,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは世界のベータニコチンアミドモノヌクレオチド (NMN)市場について調査・分析し、世界のベータニコチンアミドモノヌクレオチド (NMN)市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析(含有率98%以上、含有率98%以下)、用途別セグメント分析(ヘルスケア製品、化粧品、その他)、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomwayなどが含まれています。世界のベータニコチンアミドモノヌクレオチド (NMN)市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX%です。COVID-19とロシア・ウクライナ戦争による影響は、ベータニコチンアミドモノヌクレオチド (NMN)市場規模を推定する際に考慮しました。本レポートは、ベータニコチンアミドモノヌクレオチド (NMN)の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ベータニコチンアミドモノヌクレオチド (NMN)に関するビジネス上の意思決定に役立てることを目的としています。

・ベータニコチンアミドモノヌクレオチド (NMN)市場の概要
- 製品の定義
- ベータニコチンアミドモノヌクレオチド (NMN)のタイプ別セグメント
- 世界のベータニコチンアミドモノヌクレオチド (NMN)市場成長率のタイプ別分析(含有率98%以上、含有率98%以下)
- ベータニコチンアミドモノヌクレオチド (NMN)の用途別セグメント
- 世界のベータニコチンアミドモノヌクレオチド (NMN)市場成長率の用途別分析(ヘルスケア製品、化粧品、その他)
- 世界市場の成長展望
- 世界のベータニコチンアミドモノヌクレオチド (NMN)生産量の推定と予測(2018年-2029年)
- 世界のベータニコチンアミドモノヌクレオチド (NMN)生産能力の推定と予測(2018年-2029年)
- ベータニコチンアミドモノヌクレオチド (NMN)の平均価格の推定と予測(2018年-2029年)
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ベータニコチンアミドモノヌクレオチド (NMN)市場の競争状況およびトレンド

・ベータニコチンアミドモノヌクレオチド (NMN)の地域別生産量
- ベータニコチンアミドモノヌクレオチド (NMN)生産量の地域別推計と予測(2018年-2029年)
- 地域別ベータニコチンアミドモノヌクレオチド (NMN)価格分析(2018年-2023年)
- 北米のベータニコチンアミドモノヌクレオチド (NMN)生産規模(2018年-2029年)
- ヨーロッパのベータニコチンアミドモノヌクレオチド (NMN)生産規模(2018年-2029年)
- 中国のベータニコチンアミドモノヌクレオチド (NMN)生産規模(2018年-2029年)
- 日本のベータニコチンアミドモノヌクレオチド (NMN)生産規模(2018年-2029年)
- 韓国のベータニコチンアミドモノヌクレオチド (NMN)生産規模(2018年-2029年)
- インドのベータニコチンアミドモノヌクレオチド (NMN)生産規模(2018年-2029年)

・ベータニコチンアミドモノヌクレオチド (NMN)の地域別消費量
- ベータニコチンアミドモノヌクレオチド (NMN)消費量の地域別推計と予測(2018年-2029年)
- 北米のベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- アメリカのベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- ヨーロッパのベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- アジア太平洋のベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- 中国のベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- 日本のベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- 韓国のベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- 東南アジアのベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- インドのベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)
- 中南米・中東・アフリカのベータニコチンアミドモノヌクレオチド (NMN)消費量(2018年-2029年)

・タイプ別セグメント:含有率98%以上、含有率98%以下
- 世界のベータニコチンアミドモノヌクレオチド (NMN)のタイプ別生産量(2018年-2023年)
- 世界のベータニコチンアミドモノヌクレオチド (NMN)のタイプ別生産量(2024年-2029年)
- 世界のベータニコチンアミドモノヌクレオチド (NMN)のタイプ別価格

・用途別セグメント:ヘルスケア製品、化粧品、その他
- 世界のベータニコチンアミドモノヌクレオチド (NMN)の用途別生産量(2018年-2023年)
- 世界のベータニコチンアミドモノヌクレオチド (NMN)の用途別生産量(2024年-2029年)
- 世界のベータニコチンアミドモノヌクレオチド (NMN)の用途別価格

・主要企業のプロファイル:企業情報、製品ポートフォリオ、生産量、価格、動向
GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway

・産業チェーンと販売チャネルの分析
- ベータニコチンアミドモノヌクレオチド (NMN)産業チェーン分析
- ベータニコチンアミドモノヌクレオチド (NMN)の主要原材料
- ベータニコチンアミドモノヌクレオチド (NMN)の販売チャネル
- ベータニコチンアミドモノヌクレオチド (NMN)のディストリビューター
- ベータニコチンアミドモノヌクレオチド (NMN)の主要顧客

・ベータニコチンアミドモノヌクレオチド (NMN)市場ダイナミクス
- ベータニコチンアミドモノヌクレオチド (NMN)の業界動向
- ベータニコチンアミドモノヌクレオチド (NMN)市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
Highlights
The global Beta-Nicotinamide Mononucleotide (NMN) market was valued at US$ 256.7 million in 2022 and is anticipated to reach US$ 1075.5 million by 2029, witnessing a CAGR of 20.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, etc. Asia-Pacific is the largest producer of beta-nicotinamide mononucleotide (NMN), holds a share about 65%, followed by North America, and Europe . In terms of purity, content greater than or equal to 98% is the largest segment, with a share over 90%. And in terms of application, the largest segment is health care products, with a share over 90%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Beta-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Nicotinamide Mononucleotide (NMN).
The Beta-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Beta-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Segment by Type
Content Greater than or Equal to 98%
Content Less than 98%
Segment by Application
Health Care Products
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beta-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Beta-Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Beta-Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

レポート目次

1 Beta-Nicotinamide Mononucleotide (NMN) Market Overview
1.1 Product Definition
1.2 Beta-Nicotinamide Mononucleotide (NMN) Segment by Type
1.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Content Greater than or Equal to 98%
1.2.3 Content Less than 98%
1.3 Beta-Nicotinamide Mononucleotide (NMN) Segment by Application
1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2018-2029)
1.4.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2018-2023)
2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Beta-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Product Offered and Application
2.8 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry
2.9 Beta-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
2.9.1 Beta-Nicotinamide Mononucleotide (NMN) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Beta-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Beta-Nicotinamide Mononucleotide (NMN) Production by Region
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region (2018-2029)
3.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Beta-Nicotinamide Mononucleotide (NMN) by Region (2024-2029)
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Region (2018-2029)
3.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Beta-Nicotinamide Mononucleotide (NMN) by Region (2024-2029)
3.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2018-2023)
3.6 Global Beta-Nicotinamide Mononucleotide (NMN) Production and Value, Year-over-Year Growth
3.6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
4 Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2029)
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2023)
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2018-2029)
5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2018-2023)
5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2024-2029)
5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2018-2029)
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2018-2029)
5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2018-2023)
5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2024-2029)
5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2018-2029)
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2018-2029)
6 Segment by Application
6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029)
6.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2023)
6.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2024-2029)
6.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2018-2029)
6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2029)
6.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2023)
6.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2024-2029)
6.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2029)
6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2018-2029)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.2.2 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Genex Formulas
7.3.1 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Genex Formulas Main Business and Markets Served
7.3.5 Genex Formulas Recent Developments/Updates
7.4 Shinkowa Pharmaceutical
7.4.1 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.4.2 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Shinkowa Pharmaceutical Main Business and Markets Served
7.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Maac10 Formulas Main Business and Markets Served
7.5.5 Maac10 Formulas Recent Developments/Updates
7.6 EffePharm
7.6.1 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.6.2 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.6.4 EffePharm Main Business and Markets Served
7.6.5 EffePharm Recent Developments/Updates
7.7 Bontac
7.7.1 Bontac Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.7.2 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Bontac Main Business and Markets Served
7.7.5 Bontac Recent Developments/Updates
7.8 CELFULL
7.8.1 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.8.2 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.8.4 CELFULL Main Business and Markets Served
7.7.5 CELFULL Recent Developments/Updates
7.9 Kingdomway
7.9.1 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.9.2 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Kingdomway Main Business and Markets Served
7.9.5 Kingdomway Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
8.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process
8.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing
8.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels
8.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors
8.5 Beta-Nicotinamide Mononucleotide (NMN) Customers
9 Beta-Nicotinamide Mononucleotide (NMN) Market Dynamics
9.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends
9.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
9.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges
9.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer